Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Editas Medicine stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EDIT.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR) and Tevogen Bio Holdings (NASDAQ:TVGN).
Editas Medicine has a consensus price target of $9.26.
The stock price for Editas Medicine (NASDAQ: EDIT) is $2.7398 last updated July 15, 2025 at 7:51 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.